Gut Microbiota as a Systemic Regulator: Immunological and Neurological Implications Beyond Digestive Disease
Maria Paulina Pineda Morales, Alejandra Isabel Carla Farina Guzman, Gerardo Amaya Villagrán, Fabio Camilo Jaramillo Contreras, Cristian Arturo Abia Meashima, Janeth Elizabeth Orellana-Zárate, Jorge Angel Velasco Espinal, Dominique Isaac Núñez González · International Science Journal · 2026
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
International Science Journal · OpenAlex · article · 2026
Abstract
The gut microbiota has emerged as a fundamental regulator of systemic human physiology, extending its influence far beyond the gastrointestinal tract. Recent advances in microbiome research have demonstrated that intestinal microorganisms participate actively in metabolic regulation, immune homeostasis, neuroimmune communication, inflammatory signaling, and chronic disease progression. The present review aimed to analyze current scientific evidence regarding the relationship between gut microbiota and systemic diseases, with special emphasis on immunological and neurological implications beyond digestive pathology.
A structured narrative review methodology based on the Scientific Method was employed through analysis of peer-reviewed literature indexed in internationally recognized scientific databases including PubMed, Scopus, ScienceDirect, and SpringerLink. The review integrated multidisciplinary evidence involving gastroenterology, neurology, immunology, microbiology, metabolism, and translational medicine. The selected studies evaluated mechanisms associated with intestinal dysbiosis, systemic inflammation, gut–brain axis signaling, immune dysregulation, microbial metabolites, and microbiota-targeted therapeutic strategies.
The analyzed evidence demonstrated that alterations in gut microbial diversity are strongly associated with chronic inflammatory diseases, obesity, type 2 diabetes mellitus, cardiovascular disease, autoimmune disorders, neurodegenerative pathology, and psychiatric conditions. Key mechanisms identified included increased intestinal permeability, chronic low-grade inflammation, abnormal immune activation, altered short-chain fatty acid production, and neuroimmune dysregulation mediated through the gut–brain axis.
Furthermore, microbiota-targeted interventions such as probiotics, prebiotics, dietary modulation, postbiotics, and fecal microbiota transplantation demonstrated promising therapeutic potential in restoring microbial balance and reducing inflammatory activity.
Open the resolved locator · 10.64784/218
Metadata licence: OpenAlex metadata (CC0)